Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

NuGilead You seem to imply CytoDyn is wasting its

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155038
(Total Views: 634)
Posted On: 08/18/2019 10:26:20 AM
Avatar
Posted By: FullTilt
Re: NuGilead #6316
NuGilead
You seem to imply CytoDyn is wasting its time and valuable cash pursuing the cancer indication. Do you understand that the cancer reduction in the preclinical trials have been overwhelming successful in reducing not only tumor size but also tumor metastatic burden. The animal model of mTNBC showed a 98% reduction in metastasis! If results are even half this good in humans, our fundraising problems are over.

Image-1.jpg
https://www.cytodyn.com/newsroom/press-releas...ta-showing

Also, if you listen to the last investor conference call Dr. Bruce Patterson states he has discovered a MOA (mechanism of action) involving CCR5 on T regulatory cells, which protect the cancer from the bodies immune system. He states Leronlimab can inhibit CCR5 on the T Reg cells to allow the bodies immune system to fight the tumor without being blocked by the T Reg cells. This is HUGE!

Even more amazing Dr. Nader quotes Dr. Linder in a Proactive Investor interview stating He has discovered yet another MOA with cancer. Dr.Linder has discovered in his colon cancer research that Leronlimab stops angiogenesis! This is even MORE HUGER!

So, when you state that BP doesn’t think Leronlimab has a good chance in cancer, I think I will trust the opinion of the many leading oncology doctors working with Leronlimab!


(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us